White House investment in rapid COVID testing expected to quadruple testing supply

OAN Top News

NEW YORK, NY - APRIL 16: A COVID-19 IgG and IgM Rapid Test Cassette is displayed on April 16, 2020 in New York City. The take home test says they can tell a person if they have Coronavirus antibodies in their system, thus indicating that they have had he virus. Hospitals in New York City, which have been especially hard hit by the coronavirus, are still struggling with an influx of COVID-19 cases. (Photo by Spencer Platt/Getty Images)

NEW YORK, NY - APRIL 16: A COVID-19 IgG and IgM Rapid Test Cassette is displayed on April 16, 2020 in New York City. The take home test says they can tell a person if they have Coronavirus antibodies in their system, thus indicating that they have had he virus. Hospitals in New York City, which have been especially hard hit by the coronavirus, are still struggling with an influx of COVID-19 cases. (Photo by Spencer Platt/Getty Images)

NEW YORK, N.Y. – APRIL 16: A COVID-19 IgG and IgM Rapid Test Cassette is displayed on April 16, 2020 in New York City. (Photo by Spencer Platt/Getty Images)

OAN Newsroom
UPDATED 3:50 PM PT – Wednesday, October 6, 2021

The White House said it’s investing more money into pumping up the country’s supply of rapid at-home COVID tests. Reports on Wednesday revealed the White House is investing an additional $1 billion to increase the number of tests.

This comes in addition to the $2 billion investment announced in September. Both expenses are expected to be used to increase the number of tests four-fold by December.

Production of rapid tests will rise from around 30 million a month to 200 million and they’re expected to drop in price as well.

“This means companies will be able to expand production of tests even further based on the United States government’s commitment to procuring an additional 180 million rapid tests over the course of the next year, with tens of millions more tests coming to market over the course of the next 30 days,” announced White House COVID-19 coordinator Jeff Zients.

In the meantime, the White House also said it’s doubling its commitment to provide free testing to 20,000 pharmacies nationwide.

MORE NEWS: Rep. McCarthy: Can’t Invest In U.S. Future Under Democrat Plans

Leave a Reply